BREAST cancer is the most common invasive cancer in women, and one of the most common forms of cancer overall around the world. South Africa records the highest incidence rate for breast cancer, with a lifetime risk estimated at 1 in women.2 It is also important to note that, although rare, it has been recorded that 1 to 3% of South African men are also diagnosed with breast cancer.3
As such, Zogera Kara, Pfizer Category Lead for Vaccines, Oncology, Inflammation Immunology, said Pfizer Oncology is deeply committed to advancing scientific innovation and transforming the current state of breast cancer care for the millions of people around the world and in South Africa, who are affected by breast cancer every day.
Pfizer has a decades-long heritage in research and development, she says. “This, paired with an innovative use of technology and real-world evidence have accelerated our ability to deliver breakthrough therapies for those living with breast cancer.”